Prevention of early-onset cardiomyopathy in <i>Dmd</i> exon 52-54 deletion mice by CRISPR-Cas9-mediated exon skipping.

11% with the dual guide approach) in the heart with our single sgRNA treatment, as assessed by qRT-PCR; however, this increase did not reach statistical significance ( Figure S2 ).

also in 111,027 other papers